Aldactone / Spironolactone

Modified on 2009/10/14 21:33 by admin
Aldactone, also known as spironolactone, is indicated for the treatment of congestive heart failure, hyperaldosteronism (excessive secretion of aldosterone, a hormone that regulates salt and water balance) and nephrotic syndrome, a kidney disorder. Approved by the U.S. Food and Drug Administration in 1983, Aldactone is made by Pfizer.

Potential side effects of Aldactone include, but may not be limited to, headache, stomach disorders, vomiting, diarrhea, fever, drowsiness and frequent urination.

A report published in the August 2004 issue of the New England Journal of Medicine reveals deaths associated with Aldactone are on the rise, a trait that may be linked to an increase in prescriptions. In 1999, a major study concluded that Aldactone cut the death rate in people with heart failure by 30 percent. After the results were published, prescriptions increased dramatically, as did hospitalizations for potassium buildup and irregular heartbeats, side effects linked to Aldactone.

The new study tracked hospital records from 1994-2001 and encompassed over 1 million residents of Ontario. According to the latest report, hospitalizations and deaths linked to Aldactone tripled after 1999. During that time period, health officials estimate that over 4,000 patients in the United States have died annually from high potassium levels.

If you have experienced serious health problems after taking Aldactone, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.

See Also

  1. Heart Failure Drugs: Overview
  2. Arrhythmia: Overview
  3. Diarrhea: Overview
  4. Headaches
  Name Size